JNPMEDI announced on the 13th that they showcased their Distributed Clinical Trial (DCT) solutions based on a data platform at the ‘2023 KoNECT International Conference’ (KIC2023).
Operating an exhibition booth, JNPMEDI presented their clinical trial data management and operational platform, ‘Maven Clinical Cloud,’ along with a diverse lineup of clinical trial services.
Kwunho Jeong, CEO of JNPMEDI, chaired a special session on DCT and Smart Clinical Trials (SCT) during the event. He discussed the current status of digital therapeutics development, the application of new technologies utilizing big data and artificial intelligence (AI), and introduced DCT and futuristic clinical trials while proposing effective implementation strategies.
JNPMEDI aims to expand its outreach further. They plan to actively seek opportunities for collaboration with overseas partners while increasing their global influence through active international engagements. This strategy involves strengthening their research and development capabilities for their solutions by understanding the latest trends in global drug development and regulations. They aim to explore business models directly connected to worldwide healthcare markets, enhancing their brand competitiveness.
Jeong expressed delight in participating in an international event that acknowledges the value of their platforms and services, providing an opportunity to discuss the present and future of the clinical trial field. He emphasized their commitment to amplifying the potential of cutting-edge DCT solutions driving digital transformations, consolidating their position as a leading company driving innovation in the global clinical trial industry.